Eloxx Pharmaceuticals Inc (ELOX)

[XenaLives]

Phillip Frost named in SEC lawsuit:

Discussion here:
https://investorshub.advfn.com/SCAMS-R-US-25227/

SECURITIES AND EXCHANGE COMMISSION,
Plaintiff,

-- against --

BARRY C. HONIG, JOHN STETSON,
MICHAEL BRAUSER, JOHN R. O'ROURKE III,
MARK GROUSSMAN, PHILLIP FROST,
ROBERT LADD, ELLIOT MAZA, BRIAN KELLER,
JOHN H. FORD, ALPHA CAPITAL ANSTALT, ATG
CAPITAL LLC, FROST GAMMA INVESTMENTS
TRUST, GRQ CONSULTANTS, INC.,
HS CONTRARIAN INVESTMENTS, LLC,
GRANDER HOLDINGS, INC., MELECHDAVID,
INC., OPKO HEALTH, INC.,
SOUTHERN BIOTECH, INC., and
STETSON CAPITAL INVESTMENTS INC.,

https://www.courtlistener.com/recap/gov.uscourts.nysd.500558/gov.uscourts.nysd.500558.1.0.pdf

Frost and Eloxx:

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] SEC Accession No. 0001144204-17-065425
Filing Date
2017-12-27
Accepted
2017-12-27 13:43:37
Documents
1
Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv482101_sc13da.htm SC 13D/A 57218
Complete submission text file 0001144204-17-065425.txt 58750
Mailing Address
4400 BISCAYNE BLVD
MIAMI FL 33137-3227
Business Address
FROST PHILLIP MD ET AL (Filed by) CIK: 0000898860 (see all company filings)
Type: SC 13D/A

Mailing Address
950 WINTER STREET
WALTHAM MA 02451
Business Address
950 WINTER STREET
WALTHAM MA 02451
[phone]
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)
IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-56243 | Film No.: 171275856
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director

https://www.sec.gov/Archives/edgar/data/898860/000114420417065425/0001144204-17-065425-index.htm